1681 related articles for article (PubMed ID: 17517187)
1. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF
Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts.
Schmidt D; Breymann C; Weber A; Guenter CI; Neuenschwander S; Zund G; Turina M; Hoerstrup SP
Ann Thorac Surg; 2004 Dec; 78(6):2094-8. PubMed ID: 15561042
[TBL] [Abstract][Full Text] [Related]
4. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells.
Schmidt D; Mol A; Neuenschwander S; Breymann C; Gössi M; Zund G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2005 May; 27(5):795-800. PubMed ID: 15848316
[TBL] [Abstract][Full Text] [Related]
5. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary in vivo evaluation of tissue engineered venous grafts fabricated based on endothelial progenitor cells].
Wu YF; Zhang J; Gu YQ; Li JX; Chen XS; Chen L; Chen B; Guo LR; Luo T; Liao CJ; Wu X; Yu HX; Wang ZG
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):491-5. PubMed ID: 17686312
[TBL] [Abstract][Full Text] [Related]
7. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
[TBL] [Abstract][Full Text] [Related]
8. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
9. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
[TBL] [Abstract][Full Text] [Related]
10. Histological evaluation of tissue-engineered heart valves implanted in the juvenile sheep model: is there a need for in-vitro seeding?
Dohmen PM; da Costa F; Yoshi S; Lopes SV; da Souza FP; Vilani R; Wouk AF; da Costa M; Konertz W
J Heart Valve Dis; 2006 Nov; 15(6):823-9. PubMed ID: 17152791
[TBL] [Abstract][Full Text] [Related]
11. Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells.
Wu H; Riha GM; Yang H; Li M; Yao Q; Chen C
J Surg Res; 2005 Jun; 126(2):193-8. PubMed ID: 15919419
[TBL] [Abstract][Full Text] [Related]
12. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors.
Schmidt D; Asmis LM; Odermatt B; Kelm J; Breymann C; Gössi M; Genoni M; Zund G; Hoerstrup SP
Ann Thorac Surg; 2006 Oct; 82(4):1465-71; discussion 1471. PubMed ID: 16996955
[TBL] [Abstract][Full Text] [Related]
13. Toward engineering a human neoendothelium with circulating progenitor cells.
Allen JB; Khan S; Lapidos KA; Ameer GA
Stem Cells; 2010 Feb; 28(2):318-28. PubMed ID: 20013827
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
15. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E
J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063
[TBL] [Abstract][Full Text] [Related]
16. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
17. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
[TBL] [Abstract][Full Text] [Related]
18. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
[TBL] [Abstract][Full Text] [Related]
19. Polyelectrolyte multilayer film on decellularized porcine aortic valve can reduce the adhesion of blood cells without affecting the growth of human circulating progenitor cells.
Ye X; Hu X; Wang H; Liu J; Zhao Q
Acta Biomater; 2012 Mar; 8(3):1057-67. PubMed ID: 22122977
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of heart valve scaffold and cell seeding].
Long L; Wu C; Pan L; Qi X; Hong T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):610-3. PubMed ID: 15357443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
